These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11271409)

  • 1. 8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-like action of paroxetine in an elevated plus-maze.
    Kõks S; Beljajev S; Koovit I; Abramov U; Bourin M; Vasar E
    Psychopharmacology (Berl); 2001 Jan; 153(3):365-72. PubMed ID: 11271409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the elevated plus-maze the anxiolytic-like effects of the 5-HT(1A) agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT(1A) partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635.
    Collinson N; Dawson GR
    Psychopharmacology (Berl); 1997 Jul; 132(1):35-43. PubMed ID: 9272757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5HT(1A) and 5HT(1B) receptors of medial prefrontal cortex modulate anxiogenic-like behaviors in rats.
    Solati J; Salari AA; Bakhtiari A
    Neurosci Lett; 2011 Oct; 504(3):325-9. PubMed ID: 21982809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onset of the effects of the 5-HT1A antagonist, WAY-100635, alone, and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat.
    Cryan JF; McGrath C; Leonard BE; Norman TR
    Pharmacol Biochem Behav; 1999 Jun; 63(2):333-8. PubMed ID: 10371664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic paroxetine pretreatment on (+/-)-8-hydroxy-2-(di-n-propyl-amino)tetralin induced c-fos expression following sexual behavior.
    de Jong TR; Pattij T; Veening JG; Dederen PJ; Waldinger MD; Cools AR; Olivier B
    Neuroscience; 2005; 134(4):1351-61. PubMed ID: 16019152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability.
    Zazpe A; Artaiz I; Labeaga L; Lucero ML; Orjales A
    Neuropharmacology; 2007 Mar; 52(3):975-84. PubMed ID: 17141811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain.
    Maj J; Bijak M; Dziedzicka-Wasylewska M; Rogoz R; Rogóz Z; Skuza G; Tokarski T
    Psychopharmacology (Berl); 1996 Sep; 127(1):73-82. PubMed ID: 8880946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze.
    Gonzalez LE; Andrews N; File SE
    Brain Res; 1996 Sep; 732(1-2):145-53. PubMed ID: 8891278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis.
    Nakai K; Fujii T; Fujimoto K; Suzuki T; Kawashima K
    Neurosci Res; 1998 May; 31(1):23-9. PubMed ID: 9704975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
    Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine.
    de Jong TR; Pattij T; Veening JG; Waldinger MD; Cools AR; Olivier B
    Psychopharmacology (Berl); 2005 May; 179(2):509-15. PubMed ID: 15719219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
    De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiogenesis in adult rats treated chronically with cocaine during adolescence: effects of extended abstinence and 8-OH-DPAT treatment.
    Santucci AC; Madeira E
    Brain Res Bull; 2008 Jul; 76(4):402-11. PubMed ID: 18502317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice.
    Darmani NA; Reeves SL
    Pharmacol Biochem Behav; 1996 Sep; 55(1):1-10. PubMed ID: 8870031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of two stressors on behaviour in the elevated X-maze: preliminary investigation of their interaction with 8-OH-DPAT.
    McBlane JW; Handley SL
    Psychopharmacology (Berl); 1994 Oct; 116(2):173-82. PubMed ID: 7532313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin 2C receptors in the basolateral amygdala mediate the anxiogenic effect caused by serotonergic activation of the dorsal raphe dorsomedial subnucleus.
    Matthiesen M; Mendes LD; Spiacci A; Fortaleza EA; Corrêa FM; Zangrossi H
    J Psychopharmacol; 2020 Apr; 34(4):391-399. PubMed ID: 31637976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal asymmetry in the behavioral responses to the 5-HT1A receptor agonist 8-OH-DPAT.
    Belcheva I; Belcheva S; Petkov VV; Petkov VD
    Brain Res; 1994 Mar; 640(1-2):223-8. PubMed ID: 7911727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of 5-HT1A receptor agonists on locomotor activity in the guinea-pig.
    Evenden JL
    Br J Pharmacol; 1994 Jul; 112(3):861-6. PubMed ID: 7921613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant-induced adaptive changes in the effects of 5-HT, 5-HT1A and 5-HT4 agonists on the population spike recorded in hippocampal CA1 cells do not involve presynaptic effects on excitatory synaptic transmission.
    Tokarski K; Bijak M
    Pol J Pharmacol; 1996; 48(6):565-73. PubMed ID: 9112695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors.
    Zhang J; Huang XY; Ye ML; Luo CX; Wu HY; Hu Y; Zhou QG; Wu DL; Zhu LJ; Zhu DY
    J Neurosci; 2010 Feb; 30(7):2433-41. PubMed ID: 20164327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.